Floatz logo

Ifosfamide

Large B-cell Lymphoma

Washington University School of MedicinePhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

65 Active assets in the Large B-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Axicabtagene Ciloleucel
Zhejiang Cancer Hospital
Phase 4BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 4BB
Fludarabine
M.D. Anderson Cancer Center
Phase 4BB
PREDNISONE TABLETS
Ruijin Hospital
Phase 3BB
Inno-206
Ruijin Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

Ifosfamide is also rated in:

angioimmunoblastic T-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary mediastinal large B-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →